Type,Expense in million U.S. dollars
Stock-based compensation,48.26
Shared discovery and development expenses,59.1
Technical development and unallocated manufacturing expenses,85.3
Platform research,91.1
Discovery programs,55.38
Systemic intracellular therapeutics*,33.36
Systemic secreted and cell surface therapeutics*,11.24
Localized regenerative therapeutics*,33.26
Intratumoral immuno-oncology*,17.61
Cancer vaccines*,44.0
Prophylactic vaccines*,47.65
